Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.5066
Delayed Data
As of Mar 24
 -0.0234 / -4.42%
Today’s Change
0.39
Today|||52-Week Range
2.64
-26.56%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.53
Today’s open0.52
Day’s range0.50 - 0.52
Volume111,639
Average volume (3 months)203,872
Market cap$13.2M
Dividend yield--
Data as of 3:58pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
EVARLombard Medical Inc-0.03-4.86%
JAGXJaguar Animal Health...-0.06-5.59%
DPRXDipexium Pharmaceuti...0.000.00%
MBVXMabVax Therapeutics ...-0.24-9.56%
Data as of 3:59pm ET, 03/24/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Secretary
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts


Search for Jobs